BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 5, 2011
View Archived Issues
Preclinical and clinical phase I/II data presented on GSK-573719 for COPD
Read More
Novel SMYD2 inhibitor identified at AstraZeneca
Read More
Novel pan-Aurora kinase inhibitor is active against drug-resistant cancer cells
Read More
Novel CO-releasing rhenium complexes developed at Swiss university
Read More
Phosphagenics to advance development of twice-weekly oxycodone patch
Read More
Enrollment complete in pediatric Xerecept trial
Read More
Incozen Therapeutics describes new PI3K-delta inhibitor
Read More
Creabilis raises funds for development of CT-327
Read More
Scientists at GSK prepare new lysophospholipid S1P1 receptor agonists
Read More
Novel neuroprotective agents patented
Read More
New saRNA molecules claimed by University of California scientists
Read More
Novel PP1 inhibitors synthesized
Read More
EntreMed reports encouraging phase II results on ENMD-2076
Read More
Fibrocell Science launches laViv in U.S.
Read More
InSite Vision releases phase II pharmacokinetic data on BromSite
Read More
Intellect Neurosciences and ViroPharma enter licensing agreement for OX-1
Read More
CalciMedica presents novel protein orai-1 inhibitors
Read More
NuPathe reports encouraging data from migraine patch trial
Read More
Gliknik receives SBIR contract to advance stradobodies
Read More
Merck Serono and Ono Pharmaceutical collaborate on MS drug and cancer vaccine
Read More
G-Zero Therapeutics receives NIH grant for studies in radiation exposure
Read More
Karo Bio enrolls first patient in AKKA study
Read More
Neurocrine and Abbott reach second milestone in elagolix collaboration
Read More
First patients dosed with Xiaflex in Dupuytren's contracture multicord study
Read More
Cariprazine study meets primary endpoint
Read More